1. Home
  2. WVE vs TSAT Comparison

WVE vs TSAT Comparison

Compare WVE & TSAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

BUY

Current Price

$3.45

Market Cap

744.8M

Sector

Health Care

ML Signal

BUY

Logo Telesat Corporation

TSAT

Telesat Corporation

SELL

Current Price

$44.35

Market Cap

697.5M

Sector

Industrials

ML Signal

SELL

Company Overview

Basic Information
Metric
WVE
TSAT
Founded
2012
1969
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
744.8M
697.5M
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
WVE
TSAT
Price
$3.45
$44.35
Analyst Decision
Strong Buy
Buy
Analyst Count
19
5
Target Price
$18.06
★ $65.59
AVG Volume (30 Days)
★ 2.9M
96.3K
Earning Date
11-09-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $3,704,000.00
N/A
Revenue This Year
$19.21
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 149.43
N/A
52 Week Low
$3.43
$23.01
52 Week High
$21.73
$61.54

Technical Indicators

Market Signals
Indicator
WVE
TSAT
Relative Strength Index (RSI) 25.92 42.53
Support Level N/A $41.65
Resistance Level $6.33 $45.19
Average True Range (ATR) 0.23 2.61
MACD -0.02 -0.39
Stochastic Oscillator 8.56 14.14

Price Performance

Historical Comparison
WVE
TSAT

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Inc is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About TSAT Telesat Corporation

Telesat Corp is a satellite operator, that provides its customers with mission-critical communications services. It operates in a single operating segment, in which it provides satellite-based services to its broadcast, enterprise, and consulting customers around the world. The company has two operating segments: GEO services (GEO) segment that refers to the operation of the fleet of GEO satellite and LEO services (LEO) segment that refers to the deployment and operation of the Telesat Lightspeed constellation Geographically, it derives a majority of its revenue from Canada. It derives revenue from Broadcast, Enterprise, Consulting, and others.

Share on Social Networks: